Gr. Sarantis S.a. · ATHEX:SAR
Gr. Sarantis — Sarantis Group — Erste Conference (May 2025)
31 slides from Gr. Sarantis's conference presentation, May 2025
Slide 1: Sarantis Group Investors Presentation May 2025
Sarantis Group Investors Presentation May 2025
Slide 2: Forward-looking statement
Forward-looking statement This document contains certain “forward-looking” statements. These statements may generally, but not always, be identified by the use of words such as “outlook”, “forecast”, “objective”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “target”, “will”, “aim” and other
Slide 3: With you today
With you today Giannis Bouras Christos Varsos Group Chief Executive Officer Group Chief Financial Officer 3 Sarantis Group Investors Presentation
Slide 4: We care for the future the same way we care about the present
We care for the future the same way we care about the present OUR COMPETITIVE ADVANTAGE OUR SCOPE ▪ We design for the CEE region with deep local consumer understanding ▪ CEE and selected international markets on beauty ▪ We are the revitalisers of local “jewel” brands ▪ Home Care solutions ▪ We inve
Slide 5: Consistent organic growth with acquisitions coming on top
Consistent organic growth with acquisitions coming on top Sarantis Group Growth Drivers Beauty, Skin & Personal Home Care Strategic Sun Care Care Solutions Partnerships Disproportionate Core Profit Significant growth driver Market leverage growth Generator Complementary acquisitions on top in key pr
Slide 6: Simplification and efficiency – progress
Simplification and efficiency – progress Main projects on track – First milestones achieved ▪ Integrated ERP platform across geographies ▪ New SAP implementation: Accelerating Go-live of first wave successfully completed for digital Greece Czech Slovakia Hungary transformation ▪ Second wave to follo
Slide 7: Enhancing our international expansion footprint
Enhancing our international expansion footprint Growth Drivers for Exports 2024 Exports Beauty, Skin & Suncare to selected international markets Net Sales €19.3m +11.9% y-o-y EBIT €5.0m +41.5% y-o-y EBIT% 26.1% +545bps y-o-y 7 Sarantis Group Investors Presentation
Slide 8: Solid first-quarter performance
Solid first-quarter performance Q1 25 Net Sales € 141.9m + 0.2% Q1 25 EBITDA Robust Financial Position € 19.4m Net cash € 5.7m + 4.8% EBITDA margin 13.7% +60bps as of March 31, 2025 Q1 25 EBIT € 14.8m + 8.7% EBIT margin 10.4% +82bps 8 Sarantis Group Investors Presentation
Slide 9: Well-placed for Sustainable Growth
Well-placed for 9 Sustainable Growth *Net Sales €740m *Net Sales €660m 2X EBITDA to €120m Net Sales €600.1m Net Sales €482.2m EBITDA €81.6m EBITDA €100m 2X EBIT to 95€m Net Sales €445.1m EBITDA €61.6m EBIT €61.0m EBIT 77€m EBITDA €45.5m √ from 2023 EBIT €47.1m EBIT €32.2m 2022 2023 2024 2026 2028 Ov
Slide 10: On track to deliver our 2025 Outlook
On track to deliver our 2025 Outlook 2025 Net Sales €628.0m + 4.7% vs 2024 in line with 5-year plan for 2025 2025 EBITDA 2025 EBIT growth €92.0m €70.0m + 12.7% vs 2024 + 14.8% vs 2024 +1.9% vs 5-year plan for 2025 +3.6% vs 5-year plan for 2025 Margins expansion EBITDA% 14.6% for 2025 +100bps vs 2024
Slide 11: CAPEX Execution Plan with increased investment from 2025
CAPEX Execution Plan with increased investment from 2025 Capex 2024 2025 2026 2027 2028 Oinofyta DC* € 7.0m € 18.0m Digital* € 4.0m € 3.0m € 6.0m transformation Stella € 3.0m € 15.0m € 3.0m € 2.0m € 2.0m Rest of Group € 8.5m € 14.0m € 6.0m € 6.0m € 6.0m Total € 17.5m € 40.0m € 30.0m € 8.0m € 8.0m 5-
Slide 12: Building on strong performance in 2024
Building on strong performance in 2024 Consolidated Statement of Comprehensive income Amounts In €m FY 2024 FY 2023 Δ (unless otherwise stated) Net Sales 600.1 482.2 24.4% Gross Profit 226.2 182.3 24.1% Gross Profit margin 37.7% 37.8% - 11bps EBITDA 81.6 61.6 32.5% EBITDA margin 13.6% 12.8% + 82bps
Slide 13: 2024 category focus drove profitability
2024 category focus drove profitability FY 2024 figures NET SALES EBIT EBIT % y-o-y y-o-y y-o-y Beauty, Skin € 59.8m € 8.9m 14.9% & Sun Care + 24.1% + 65.5% + 373bps Personal € 116.5m € 17.9m 15.4% Care + 13.4% + 36.0% + 257bps Home Care € 212.0m €24.4m 11.5% Solutions + 29.2% + 9.2% - 211bps € 59.8
Slide 14: Strong growth across our geographies
Strong growth across our geographies FY 2024 figures NET SALES EBIT EBIT% y-o-y y-o-y y-o-y NET SALES EBIT EBIT% y-o-y y-o-y y-o-y € 170.6m € 21.7m 12.7% Greece € 170.6m € 21.7m 12.7% + 9.3% + 31.0% + 210bps Greece + 9.3% + 31.0% + 210bps € 184.1m € 10.6m 5.7% Poland Domestic market € 151.3m € 16.7m
Slide 15: Enhancing shareholders value
Enhancing shareholders value AGM approved 2024 dividend payment of €20.0m (+33.3% to PY) €0.31 per share Dividend payout ratio 43.5% (vs 38.2% in the PY) EPS €0.7125 Share buy-back per share program (+ 20.8%) in place 15 Sarantis Group Investors Presentation
Slide 16: Raising Corporate Governance Standards
Raising Corporate Governance Standards New Board of Directors * Executive Directors Long-term incentive scheme updated: ✓ 4 Executive Directors * ✓ Running in three-year performance cycles Kyriakos Sarantis, Chairman of the ✓ Targets for 2023-2025 & 2024-2026 cycles: EBITDA margin, ✓ 6 Non-Executive
Slide 17: Committing to Science-Based Targets initiative (SBTi)-aligned targets
Committing to Science-Based Targets initiative (SBTi)-aligned targets We align our strong financial performance with measurable sustainability initiatives that drive business value 2023 2026 2027 2030 2050 we commit to setting a we commit to Net-zero mid-term CO2 scope 3 carbon footprint across the
Slide 18: Why Sarantis has a strong Investment Case
Why Sarantis has a strong Investment Case ▪ Sustainable organic growth engine 01 ▪ Leading presence in our geographies ▪ Strong brand portfolio in the right categories ▪ Strong supply chain footprint with continuous investment plan 2X EBITDA in 5 years from 2023 ▪ 02 ▪ Consistent dividend ~ 38% or m
Slide 19: Appendix
Appendix
Slide 20: A long history of 60 years
A long history of 60 years 2015 Milestone acquisitions: 1964 Establishment of 1994 New production facilities Polipak, Ergopack, Stella GR. SARANTIS S.A. 2000 in Athens 2024 Pack Expansion in Eastern Investments in Europe infrastructure New exclusive strategic agreements Intense Acquisition Listed on
Slide 21: Delivering Strong Shareholder Value
Delivering Strong Shareholder Value 5-Year Plan* *as communicated during the Investor Day in March 2024
Slide 22: Disproportional growth on Beauty & Skin care
Disproportional growth on Beauty & Skin care CAGR Net Sales (€m) 2023 2024* 2025 2026 2027 2028 2023-2028 Own brands 349.6 454.3 481.7 509.0 537.7 568.7 10.2% Beauty & Skin Care 48.2 57.2 70.0 77.7 87.1 99.7 15.7% Personal Care 102.8 108.1 112.7 120.1 127.8 134.9 5.6% Home Care 198.7 288.9 299.1 311
Slide 23: Doubling the EBITDA Organically in the next 5 years
Doubling the EBITDA Organically in the next 5 years (€m) 2023 2024* 2025 2026 2027 2028 Net Sales 482.2 595.2 627.9 662.5 698.9 737.4 %YoY 23.5% 5.5% 5.5% 5.5% 5.5% Gross Margin 182.0 225.1 239.3 254.5 270.6 287.6 % on NS 37.8% 37.8% 38.1% 38.4% 38.7% 39.0% A&P 28.6 33.9 37.2 40.6 41.5 42.4 % on NS
Slide 24: Investing for our future - Capex
Investing for our future - Capex Capex 2024 2025 2026 2027 2028 Oinofyta DC* € 7.0m € 18.0m Digital* € 5.0m € 4.0m € 3.0m transformation Stella € 3.0m € 6.0m € 5.0m € 2.0m € 2.0m Rest of Group € 5.0m € 5.0m € 4.0m € 6.0m € 6.0m Total € 20.0m € 33.0m € 12.0m € 8.0m € 8.0m €81.0 million investment pla
Slide 25: A business with Strong Free Cash Flow generation
A business with Strong Free Cash Flow generation € million 2023 2024 2025 2026 2027 2028 EBITDA 61.6 80.2 90.3 100.5 110.3 120.2 Tax 9.6 10.2 11.5 13.3 14.9 16.5 Working capital change (7.2) 14.1 0.8 (0.6) 0.4 2.2 Capex 7.3 20.0 33.0 12.0 8.0 8.0 Estee Lauder Sale Receivable 20.6 20.6 FCF 51.9 35.9
Slide 26: Our brands
Our brands Beauty, Skin & Sun Care Personal Care
Slide 27: Our brands – Home Care Solutions
Our brands – Home Care Solutions
Slide 28: Strategic Partnerships – Mass Distribution
Strategic Partnerships – Mass Distribution
Slide 29: Strategic Partnerships – Selective Distribution
Strategic Partnerships – Selective Distribution
Slide 30: Recent Acquisitions
Recent Acquisitions 2014 2015 2015 2018 2018 2020 2024 Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition ✓ Cosmetics brand ✓ Hand-dishwashing ✓ Production of PL ✓ Cosmetics brand ✓ Leading player in the ✓ Cosmetics br
Slide 31: Q&A
Q&A For further information on Sarantis Group please visit our website at https://sarantisgroup.com/ or contact our Investor Relations team: Eleni Moustakidou Investor Relations Manager emoustakidou@sarantisgroup.com +30 210 6173065